1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63F4356C33E88CA81852575F900343495
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-resources-structures-trends?opendocument
18
19opendocument
203.239.76.211
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Medical Affairs » Medical Affairs Excellence

Medical Affairs Resources, Structures & Trends

DB Image

Download FREE Excerpt

ID: 5049

Features:

2 Info Graphics

21 Data Graphics

118 Metrics

20+ Narratives

Pages/Slides: 40

Published: Pre-2019

Delivery Format: Online PDF Document

 

License Options:


Buy Now

 

919-403-0251
Schedule a Meeting
Request a Quote


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Medical Affairs Resources, Structures & Trends"


Study Overview

Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency. As such, forward-looking biopharmaceutical executives are evaluating Medical Affairs operations to ensure it is appropriately structured and resourced to operate effectively in the current environment.

This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations. The study also examines recent trends in budget and staffing resources, key challenges and top success factors for the function. Pharmaceutical, biotech and medical device managers and executives will be able to use this research to determine how their Medical Affairs organizations compare with industry benchmarks.

Key Topics

  • Organizational Structure
  • Reporting Relationship
  • Job Level of Group Leader
  • Geographic Span
  • Budget Allocation by Medical Affairs Function
  • Percent of Budget Allocated for Outsourcing
  • Recent and Anticipated Changes in Resource Levels
  • Impact of Medical Affairs Functions on Company Success
  • Key Success Factors for Medical Affairs
  • Key Challenges for Medical Affairs
  • Appendix

Key Metrics
  • Type of structure (centralization)
  • Medical Affairs group dedication
  • Departmental reporting relationships
  • Job level or Medical Affairs head
  • Geographic span of organization
  • Percentage of spending per Medical Affairs function
  • Directional trends in Medical Affairs funding levels
  • Directional trends in staffing levels
  • Reasons cited for budget/staff increases
  • Reasons cited for budget/staff decreases
  • Relative importance of seven different Medical Affairs functions
  • Reasons cited for increased importance
  • Reasons cited for decreased importance
  • Percentage of budget allocated for outsourcing
  • Percent of companies impacted by FDA Revitalization Act
  • Top three success factors for developing and maintaining effective Medical Afffairs group
  • Top three challenges for developing and maintaining effective Medical Afffairs group

Sample Key Findings

1. Structure: The Medical Affairs organization is most often a centralized, dedicated group with a global geographic span that includes the U.S. Typically, Medical Affairs organizations report to the Executive Team (42 percent) rather than to Marketing or R&D. The head of Medical Affairs holds the job level of vice president or above at a majority of companies (54 percent.)

2. Spending: On average, 37 percent of Medical Affairs spending is allocated for medical/clinical research operations, with the top quartile spending more than 60 percent for the clinical function. Medical Educations takes up about 18 percent of Medical Affairs allocations.

Methodology

Twenty-six Medical Affairs leaders at 25 pharmaceutical companies participated in this benchmarking research project.

Industries Profiled:
Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care


Companies Profiled:
Amgen; Astellas; AstraZeneca Pharmaceuticals; Bayer Schering AG; Bayer; Auxilium; Becton Dickinson; Bristol-Myers Squibb; Cubist Pharmaceuticals; Esteve; Genentech; Johnson & Johnson; Myriad; Novartis; Novo Nordisk; Pfizer; Schering-Plough; Solvay Pharmaceuticals; Vertex Pharmaceuticals; ApoPharma; OctoPlus; Procaps; Savient; SK&F; Werrick

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

RELATED RESEARCH